Anti-PD-1/L1-associated immune-related adverse events as harbinger of favorable clinical outcome: systematic review and meta-analysis.

Robin ParkL LopesA Saeed

Published in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2020)

irAEs predict OR, OS, and PFS across different types of cancer and may represent useful biomarkers in the clinical setting.

Keyphrases

papillary thyroid
squamous cell
young adults